ALLR
Allarity Therapeutics, Inc.Company with tickers: ALLR
CIK
1860657
CUSIP
016744500
Shares Outstanding
15,910,724
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-01-28 | Jensen Thomas | CEO | Award | 200,000 |
| 2026-01-28 | McLaughlin Gerald W. | Director | Award | 45,000 |
| 2026-01-28 | Ervin Jeffrey S | CHIEF FINANCIAL OFFICER | Award | 150,000 |
| 2026-01-07 | Hoeiland Jesper | Director | Award | 25,000 |
| 2026-01-07 | Graff Jeremy R. | See Remarks | Award | 133,333 |
| 2025-09-30 | Graff Jeremy R. | See Remarks | Convert | 39,494 |
| 2025-09-30 | Graff Jeremy R. | See Remarks | Convert | 39,494 |
| 2025-09-30 | Graff Jeremy R. | See Remarks | Tax | 14,613 |
| 2025-07-01 | Ervin Jeffrey S | CHIEF FINANCIAL OFFICER | Other | 0 |
| 2025-06-10 | Hoeiland Jesper | Director | Other | 0 |
| 2025-01-22 | Epshinsky Alexander | CFO | Award | 29,496 |
| 2025-01-22 | Graff Jeremy R. | See Remarks | Award | 144,441 |
| 2025-01-22 | Benjamin Laura | Director | Award | 25,000 |
| 2025-01-22 | Jensen Thomas | CEO | Award | 396,734 |
| 2025-01-22 | McLaughlin Gerald W. | Director | Award | 25,000 |
| 2025-01-22 | Vazzano Joseph Walter | Chief Financial Officer | Award | 25,000 |
| 2024-09-30 | Graff Jeremy R. | See Remarks | Award | 118,483 |
| 2024-09-30 | Graff Jeremy R. | See Remarks | Other | 0 |
| 2024-09-12 | Epshinsky Alexander | CFO | Other | 55,555 |
| 2023-08-01 | Benjamin Laura | Director | Other | 0 |
| 2023-08-01 | Vazzano Joseph Walter | Chief Financial Officer | Other | 0 |
| 2022-10-01 | McLaughlin Gerald W. | Director | Other | 0 |
| 2022-07-07 | Roth David | Director | Other | 0 |
| 2022-06-29 | Brown Joan Yvonne | Chief Financial Officer | Other | 0 |
| 2022-06-27 | Knudsen Jens Erik | Former Chief Financial Officer | Other | 0 |
| 2021-12-20 | Jensen Thomas | CEO | Other | 0 |
| 2021-12-20 | Jensen Thomas | CEO | Other | 17,841 |
| 2021-12-20 | Sass Leon | 10% Owner | Other | 1,064,770 |
| 2021-12-20 | Sass Leon | 10% Owner | Other | 21,468 |
| 2021-12-20 | Knudsen Jens Erik | Former Chief Financial Officer | Other | 0 |
| 2021-12-20 | Knudsen Jens Erik | Former Chief Financial Officer | Other | 0 |
| 2021-12-20 | Knudsen Jens Erik | Former Chief Financial Officer | Other | 0 |
| 2021-12-20 | Moore Duncan | Director | Other | 0 |
| 2021-12-20 | Moore Duncan | Director | Other | 22,672 |
| 2021-12-20 | Knudsen Steen | Chief Scientific Officer | Other | 0 |
| 2021-12-20 | Knudsen Steen | Chief Scientific Officer | Other | 1,603 |
| 2021-12-20 | Knudsen Steen | Chief Scientific Officer | Other | 123,373 |
| 2021-12-20 | Cullem James G. | SVP, Chief Business Officer | Other | 0 |
| 2021-12-20 | Cullem James G. | SVP, Chief Business Officer | Other | 0 |
| 2021-12-20 | Carchedi Steve | Director, Chief Executive Officer | Other | 0 |
| 2021-12-20 | Carchedi Steve | Director, Chief Executive Officer | Other | 0 |
| 2021-12-20 | Carchedi Steve | Director, Chief Executive Officer | Other | 0 |
| 2021-12-20 | Jensen Soren Gade | Director | Other | 0 |
| 2021-12-20 | Jensen Soren Gade | Director | Other | 0 |
| 2021-12-20 | Jensen Soren Gade | Director | Other | 2,800 |
| 2021-12-20 | Foegh Marie | Chief Medical Officer | Other | 3,988 |
| 2021-12-20 | Foegh Marie | Chief Medical Officer | Other | 0 |
| 2021-12-20 | Maderis Gail J | Director | Other | 0 |
| 2021-12-20 | Maderis Gail J | Director | Other | 0 |